E-prescribing Market: The Erx Solutions Segment Accounted Largest Share


Posted April 6, 2017 by mmvaidya01

The global e-prescribing market is expected to reach USD 1,403.2 Million by 2021 from USD 546.5 Million in 2016, at a CAGR of 20.8% during the forecast period.

 
Browse 137 market data tables and 40 figures spread through 188 pages and in-depth TOC on "E-prescribing Market"
http://www.marketsandmarkets.com/Market-Reports/e-prescription-systems-market-910.html
Early buyers will receive 10% customization on this report.

Various government initiatives and incentive programs, rising focus on the reduction of fraud & abuse of controlled substances, increasing focus on reducing medical errors, and the need to curtail escalating healthcare costs are the major factors driving the growth of the global e-prescribing market.

On the basis of product, the e-prescribing services segment is expected to witness the highest growth during the forecast period.

Get The PDF Brochure For This Report:
http://www.marketsandmarkets.com/pdfdownload.asp?id=910

The high growth rate of the e-prescribing services segment can be attributed to the increasing adoption of e-prescribing that lead to a growing demand for training & education services; stringent regulations that have increased the application of implementation services for the validation & verification of hardware & software; and the need for frequent support and maintenance.

Based on delivery mode, the web & cloud-based segment is expected to dominate the market, with the highest growth rate during the forecast period. This growth of web & cloud-based segment can be primarily attributed to the improved performance and reliability by avoiding long deployment cycles, minimized upfront investments without incurring high infrastructure costs as the user can access the software from any compatible system using an access id or username and password, and that it does not require any complicated installation or implementation. The market is witnessing a shift from on-premise systems to web-hosted deployment of e-prescribing solutions.

Speak to Research Analyst:
http://www.marketsandmarkets.com/speaktoanalyst.asp?id=910

On the basis of end user, the hospitals segment is expected to grow at the highest rate during the forecast period. The major factors contributing to the high growth of this segment are the rising adoption rate of the e-prescribing solutions by hospitals in the U.S. and Europe, growing need to improve the profitability of healthcare operations, and growing focus to improve patient safety and advantages of e-prescribing over conventional handwritten prescribing systems.

The government initiatives to improve the quality of care delivered to patients and curtailing the soaring healthcare costs are also driving the adoption of e-prescribing solutions in hospitals.

Asia-Pacific possesses lucrative growth potential for the e-prescribing market during the forecast period. The high growth of this region can be attributed to healthcare organizations in the Asia-Pacific region that are actively moving towards digitization with a focus on streamlining their entire workflow and ensuring patient safety, a high share of the geriatric population resulting in significant growth in the prevalence of chronic diseases and increasing the burden of healthcare providers. The hospitals in Japan are widely adopting best practices such as healthcare information exchange, e-prescribing, and electronic health record systems to provide quality care to patients.

About MarketsandMarkets™:
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Rohan
MarketsandMarkets™
701 Pike Street
Suite 2175, Seattle,
WA 98101, United States
Tel: 1-888-600-6441
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Makarand Vaidya
Country United States
Categories Medical , Research , Science
Tags eprescribing , eprescribing market , electronic medical records , global eprescribing market
Last Updated April 6, 2017